CClinicalTrials.gg
CompletedNCT05037084Updated Jun 18, 2025

Activity and Health in Nursing Homes

An observational study in Old Age and Frailty, sponsored by Norwegian University of Science and Technology. Completed at 1 site in Norway. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-06-18.

Sponsored by Norwegian University of Science and Technology · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
1,123
Ages
65 Years and older
Sex
All
01

Study summary

There is expected to be an increased need for full time nursing homes as the increase in number of older adults increases and the rate of dementia diagnosis happens simultaneous with the decrees of healthcare personnel the years to come. A lift in knowledge is needed to provide a better and more efficient healthcare to be better equipped to meet this societal challenge. Physical activity and sleep are important indicators of health, but also on effect of treatment and care for this frail population. Comprehensive mapping of personnel time spent on different tasks and older adults' physical function throughout a week gives a unique opportunity to gain new knowledge about everyday life in nursing homes. The main aim of this project is to describe associations between physical behavior, sleep and symptoms in residents in nursing homes in Trondheim Municipality and combine these with personnel time spent on different working tasks.

02

Conditions studied

  • Old Age
  • Frailty

Browse trials for

Keywords

  • Nursing home
  • Physical activity
03

In context

Frailty

1,199 studies on the registry are indexed under Frailty; 430 are open to participants now.

This study's enrollment of 1,123 is above the median of 223 across 496 observational studies indexed under Frailty.

Browse Frailty studies →

Lead sponsor

Norwegian University of Science and Technology is the lead sponsor of 487 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All residents living full time in nursing homes. These are often frail older adults with reduced physical function, high number of medications and comorbidities.

Inclusion criteria

All residents in nursing homes in Trondheim Municipality.

Exclusion criteria

Exclusion Criteria:

Terminal residents or residents that can not stand or walk a few steps independently.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
1,123 participants (actual)
Patient registry
No

Interventions

  • Otherno intervention

    no intervention

06

What researchers measure

Primary outcomes

  1. Axivity accelerometer

    Activity monitoring

    Time frame: 7 days

  2. Somnofy sleepmonitor

    Sleep monitoring

    Time frame: 7 days

  3. Short Physical Performance Battery (SPPB)

    Measurement of physical function

    Time frame: Baseline

Secondary outcomes

  1. Time register

    Time used on different tasks during the work day

    Time frame: 7 days

  2. Neuropsychiatric Inventory (NPI)

    provide a brief assessment of neuropsychiatric symptomatology in routine clinical practice settings

    Time frame: Baseline

  3. Dementia Staging Instrument (CDR)

    characterize six domains of cognitive and functional performance applicable to Alzheimer disease and related dementias

    Time frame: Baseline

07

Study locations

1 site
  • Trondheim Kommune
    Trondheim, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05037084
Lead sponsor
Norwegian University of Science and Technology
Collaborators
Trondheim Kommune
Responsible party
Sponsor
First posted
Sep 8, 2021
Start date
Aug 30, 2021
Primary completion
May 31, 2022
Completion
May 31, 2022
Last update
Jun 18, 2025

Study contacts

Ingrid Olsen
study chair · Trondheim Kommune

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion